| __timestamp | Bristol-Myers Squibb Company | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 3932000000 | 22622695 |
| Thursday, January 1, 2015 | 3909000000 | 24863028 |
| Friday, January 1, 2016 | 4946000000 | 21351001 |
| Sunday, January 1, 2017 | 6066000000 | 53837297 |
| Monday, January 1, 2018 | 6547000000 | 16080096 |
| Tuesday, January 1, 2019 | 8078000000 | 18525736 |
| Wednesday, January 1, 2020 | 11773000000 | 2024000 |
| Friday, January 1, 2021 | 9940000000 | 2548000 |
| Saturday, January 1, 2022 | 10137000000 | 61556000 |
| Sunday, January 1, 2023 | 10693000000 | 188157000 |
| Monday, January 1, 2024 | 11949000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue for two prominent companies: Bristol-Myers Squibb Company and Telix Pharmaceuticals Limited, from 2014 to 2023.
Bristol-Myers Squibb, a giant in the pharmaceutical sector, has seen its cost of revenue grow significantly over the years. From 2014 to 2023, the cost of revenue increased by approximately 172%, peaking in 2020 at over $11 billion. This growth reflects the company's expanding operations and increased production costs.
In contrast, Telix Pharmaceuticals, a smaller player, experienced a dramatic rise in its cost of revenue, especially in recent years. From a modest $2 million in 2020, it surged to nearly $188 million by 2023, marking an exponential growth of over 9000%. This indicates Telix's rapid expansion and scaling efforts in the competitive market.
Cost Insights: Breaking Down Eli Lilly and Company and Telix Pharmaceuticals Limited's Expenses
Comparing Cost of Revenue Efficiency: Amgen Inc. vs Bristol-Myers Squibb Company
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Incyte Corporation
Bristol-Myers Squibb Company vs Telix Pharmaceuticals Limited: Annual Revenue Growth Compared
Cost of Revenue: Key Insights for Bristol-Myers Squibb Company and Pharming Group N.V.
Analyzing Cost of Revenue: Biogen Inc. and Telix Pharmaceuticals Limited
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Amneal Pharmaceuticals, Inc.'s Expenses
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Ionis Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Comparison: Telix Pharmaceuticals Limited vs Xenon Pharmaceuticals Inc.
Cost of Revenue Comparison: Telix Pharmaceuticals Limited vs PTC Therapeutics, Inc.
Analyzing Cost of Revenue: Telix Pharmaceuticals Limited and Vericel Corporation
Cost of Revenue: Key Insights for Telix Pharmaceuticals Limited and Wave Life Sciences Ltd.